Polling Question

Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.

The HypoDE randomized control trial demonstrated that:
a. Usage of RT-CGM reduced the number of hypoglycemic events in individuals with type 2 diabetes treated by MDI and with impaired hypoglycemia awareness or severe hypoglycemia
b. Usage of RT-CGM reduced the number of hypoglycemic events in individuals with type 1 diabetes treated by MDI and with impaired hypoglycemia awareness or severe hypoglycemia
c. The mean number of hypoglycemic events per 28 days among participants in the RT-CGM group was reduced from 10.8 to 2.2
d. Usage of RT-CGM is not predictable in 28 days and longer studies are recommended

Submit
©2020 CogniMed Inc. All rights reserved.